Psychobiological Mechanisms of Stress & Smoking Relapse

描述（由申请人提供）：烟草成瘾是癌症和心血管疾病的主要可预防原因。虽然在过去的二十年里，人们加快了制定有效戒烟策略的努力，但长期成功率令人失望。大多数吸烟者在尝试戒烟后两周内复发。压力是吸烟复吸最常见的诱因之一。应激诱发复发的机制尚不清楚。如果不具体了解吸烟者与压力相关的心理生物学变化，减少吸烟复吸的有针对性的努力将仍然有限。我们研究的长期目标是确定吸烟复吸的心理生物学机制。这个项目的具体目标是确定在戒烟早期和急性应激反应中垂体肾上腺皮质活动的变化在多大程度上预测试图戒烟的吸烟者的复发。我们的中心假设是，夸大的促肾上腺皮质激素（ACTH）和皮质醇的变化，在早期戒断，在动态监测和应激反应，预测复发的时间。这一假设是基于我们以前的研究和观察，心理社会压力增加吸烟复吸的风险。拟议的研究将包括在参与者仍以正常速率（基线）吸烟的24小时内以及在戒烟24-48小时期间，对昼夜皮质醇水平和皮质醇觉醒上升进行动态测量。本研究还将包括在两次实验室应激期间（随意吸烟期间和戒烟48小时后）测量血浆ACTH、皮质醇、血压和戒断症状。在每个环节中，参与者将进行三项压力挑战（公开演讲，数学和冷加压）。本研究的重点是下丘脑-垂体-肾上腺皮质轴，一个重要的生物系统最近牵连成瘾。该研究整合了激素，血液动力学和心理指标，以确定吸烟者在戒烟尝试的关键时期的压力反应模式，并以前瞻性的方式使用这些信息来确定12个月内复发的特定生物行为标志物。这项研究的一个重要目标是确定男性和女性之间心理生物学变化的差异，并确定这些差异预测复发的程度。研究结果对于为有兴趣戒烟和复发风险高的吸烟者制定最佳诊断和干预策略至关重要。降低复吸率将大大有助于减少烟草使用及其破坏性影响。

DESCRIPTION (provided by applicant): Tobacco addiction is the leading preventable cause of cancer and cardiovascular diseases. Although the last two decades have witnessed accelerated efforts to develop effective smoking cessation strategies, the long-term success rates have been disappointing. The majority of smokers relapse within two weeks of a cessation attempt. Stress is one of the most commonly reported precipitants of smoking relapse. Mechanisms responsible for the stress-precipitated relapse are not known. Without specific knowledge of the stress-related psychobiological changes in smokers, targeted efforts to reduce smoking relapse will remain limited. The long-term goal of our research is to determine the psychobiological mechanisms responsible for smoking relapse. The specific goal of this project is to determine the extent to which changes in the pituitaryadrenocortical activity during early abstinence and in response to acute stress predict relapse in smokers attempting to quit. Our central hypothesis is that exaggerated adrenocorticotropic hormone (ACTH) and cortisol changes during early abstinence, as measured during ambulatory monitoring and in response to stress, predict time to relapse. This hypothesis is based on our previous studies and on the observation that psychosocial stressors increase the risk for smoking relapse. The proposed study will include ambulatory measurement of diurnal cortisol levels and awakening rise in cortisol during 24 hours while participants are still smoking at their normal rates (baseline), and during the period of 24-48 hours of abstinence. The study will also include measurement of plasma ACTH, cortisol, blood pressure, and withdrawal symptoms during two laboratory stress sessions (during ad libitum smoking and after 48 hours of abstinence). During each session participants will perform three stressful challenges (public speaking, math, and cold pressor). This research focuses on the hypothalamic-pituitary-adrenocortical axis, an important biological system recently implicated in addiction. The research integrates hormonal, hemodynamic, and psychological indices to determine stress response patterning among smokers during this critical period of a quit attempt, and uses this information in a prospective fashion to identify specific biobehavioral markers of relapse over a 12-month period. An important goal for this research is to determine differences in psychobiological changes between men and women, and establish the extent to which these differences predict relapse. The results will be important in the development of optimal diagnostic and intervention strategies for smokers interested in cessation and at high risk for relapse. Reducing relapse rates will contribute significantly towards decreasing tobacco use and its devastating effects.